SCHEMBL5327693

SCHEMBL5327693

O=C(OC(Cl)CCl)C(Cl)Cl

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22729367 0.78 TP53 (0.30) TP53TSHRTDP1
SCHEMBL9314301 0.76
SCHEMBL22729368 0.76
SCHEMBL4297352 0.74
SCHEMBL1041196 0.74
SCHEMBL28117336 0.71
SCHEMBL5178393 0.70
SCHEMBL11295134 0.69
SCHEMBL2930252 0.69
SCHEMBL1951992 0.67 TSHR (0.42) TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1781655-A2 TRIAZOLOPYRIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATION Pharmacia & Upjohn Company LLC (US) 2007-05-09 EP disclosed
WO-2006018727-A2 TRIAZOLOPYRIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATION PHARMACIA & UPJOHN COMPANY LLC (US) 2006-02-23 WO disclosed